Discontinuation of bevacizumab and FOLFIRI administered up to a maximum of 12 cycles as first-line therapy for metastatic colorectal cancer: a retrospective Italian study

✍ Scribed by Gerardo Rosati, Stefano Cordio, Giuseppe Aprile, Alfredo Butera, Antonio Avallone, Giuseppe Di Lucca, Federica De Pauli, Hector Soto Parra, Giorgio Reggiardo, Roberto Bordonaro

• Book ID: 118299040
• Publisher: Springer US
• Year: 2011
• Tongue: English
• Weight: 179 KB
• Volume: 30
• Category: Article
• ISSN: 0167-6997
• DOI: 10.1007/s10637-011-9721-6